Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J H Scott

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Angewandte Chemie (International Ed. in English)|June 26, 2009
Methods for the incorporation of carbon-11 to generate radiopharmaceuticals for PET imagingPeter J H Scott
ACS Chemical Neuroscience|July 21, 2021
A Picture Is Worth a Thousand Words: The Power of NeuroimagingPeter J H Scott
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2024
Can we use PET to quantify mu opioid receptors across the monkey brain, spinal cord and peripheral organs at the same time? Totally!Peter J H Scott
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2022
Unnatural amino acids offer new hope for accurate bacterial infection PET imaging in prosthetic joint infectionPeter J H Scott
Angewandte Chemie (International Ed. in English)|January 4, 2012
Novel strategies for fluorine-18 radiochemistryRyan Littich, Peter J H Scott
Expert Review of Molecular Diagnostics|July 26, 2024
[<sup>68</sup>Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancerJessica Clore, Peter J H Scott
Nuclear Medicine and Biology|November 5, 2017
Is logP truly dead?Michael R Kilbourn, Peter J H Scott
Seminars in Nuclear Medicine|August 23, 2017
Guest EditorialAmy L Vāvere, Peter J H Scott
Nuclear Medicine and Biology|April 10, 2024
The future of the radiopharmaceutical sciencesSuzanne E Lapi, Peter J H Scott
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|June 22, 2007
Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human usePeter J H Scott, Michael R Kilbourn
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Angewandte Chemie (International Ed. in English)|June 26, 2009
Methods for the incorporation of carbon-11 to generate radiopharmaceuticals for PET imagingPeter J H Scott
ACS Chemical Neuroscience|July 21, 2021
A Picture Is Worth a Thousand Words: The Power of NeuroimagingPeter J H Scott
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2024
Can we use PET to quantify mu opioid receptors across the monkey brain, spinal cord and peripheral organs at the same time? Totally!Peter J H Scott
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2022
Unnatural amino acids offer new hope for accurate bacterial infection PET imaging in prosthetic joint infectionPeter J H Scott
Angewandte Chemie (International Ed. in English)|January 4, 2012
Novel strategies for fluorine-18 radiochemistryRyan Littich, Peter J H Scott
Expert Review of Molecular Diagnostics|July 26, 2024
[<sup>68</sup>Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancerJessica Clore, Peter J H Scott
Nuclear Medicine and Biology|November 5, 2017
Is logP truly dead?Michael R Kilbourn, Peter J H Scott
Seminars in Nuclear Medicine|August 23, 2017
Guest EditorialAmy L Vāvere, Peter J H Scott
Nuclear Medicine and Biology|April 10, 2024
The future of the radiopharmaceutical sciencesSuzanne E Lapi, Peter J H Scott
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|June 22, 2007
Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human usePeter J H Scott, Michael R Kilbourn
Pageof 22